Haber Trilix Advisors’s Gilead Sciences GILD Stock Holding History

Haber Trilix Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$109K	Buy	+2,120	New	+$111K	0.01%	170

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Haber Trilix Advisors's GILD Position: Q2 2013 in Review

Haber Trilix Advisors opened a new position in Gilead Sciences (GILD) in Q2 2013: 2,120 shares worth $109K. The stake represents 0.01% of the portfolio and ranks #170 among its holdings.

948 funds tracked by Wall St. Rank hold GILD as of Q2 2013.

Haber Trilix Advisors held 2,120 shares of Gilead Sciences worth $109K as of Q2 2013.
Gilead Sciences was a new Haber Trilix Advisors position in Q2 2013.
Gilead Sciences made up 0.01% of Haber Trilix Advisors's portfolio in Q2 2013, its #170 holding.
948 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2013.

Based on Haber Trilix Advisors's 13F filing for Q2 2013, filed 14 Aug 2013.